Atorvastatin calcium salt trihydrate

• 产品号: PZ0001
• CAS号: 134523-03-8(anhydrous)
• 分子式: C66H74CaF2N4O13
• 分子量: 1209.3875664
• 纯 度: ≥98% (HPLC)
• 保 存: protect from light

产品别名

• 标题: Atorvastatin calcium salt trihydrate
• IUPAC标准名: trihydrate {[(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl]oxy}calcio (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate
• IUPAC传统名: trihydrate {[(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxyheptanoyl]oxy}calcio (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxyheptanoate

产品登记号

• MDL号: MFCD09752074
• CAS号: 134523-03-8(anhydrous)

产品性质

• Empirical Formula (Hill Notation): C33H34FN2O5 · 0.5 Ca · 1.5 H2O
• 纯度: ≥98% (HPLC)
• 外观: white powder
• 溶解度: DMSO: ≥10 mg/mL
• 保存条件: protect from light
• 保存温度: room temp
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Atorvastatin calcium salt trihydrate is a specific inhibitor of HMG-CoA reductase. HMG-CoA reductase is the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, an early step in cholesterol biosynthesis. Atorvastatin is used in the treatment of hypercholesterolemia.

详细说明 (简体中文)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Atorvastatin calcium salt trihydrate is a specific inhibitor of HMG-CoA reductase. HMG-CoA reductase is the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, an early step in cholesterol biosynthesis. Atorvastatin is used in the treatment of hypercholesterolemia.